Search

Your search keyword '"Ing, Douglas"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Ing, Douglas" Remove constraint Author: "Ing, Douglas"
43 results on '"Ing, Douglas"'

Search Results

2. Uso de los tutoriales inteligentes en los procesos formativos universitarios contemporáneos

8. Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: importance of the bifurcation angle

10. N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up

17. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

22. Association Between Drug-Eluting Stent Type and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention

26. Inhibition of sPLA2 and Endothelial Function: A Substudy of the SPIDER-PCI Trial

27. Response to Letter Regarding Article, “The sPLA 2 Inhibition to Decrease Enzyme Release After Percutaneous Coronary Intervention (SPIDER-PCI) Trial”

30. The sPLA 2 Inhibition to Decrease Enzyme Release After Percutaneous Coronary Intervention (SPIDER-PCI) Trial

31. THE SPLA2 INHIBITION TO DECREASE ENZYME RELEASE AFTER PERCUTANEOUS CORONARY INTERVENTION (SPIDER-PCI) TRIAL.

32. The Adverse Long-Term Impact of Renal Impairment in Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era

34. In-hospital outcome is improved in women after percutaneous coronary intervention and is similar to that in men in the era of routine platelet glycoprotein IIb/IIIa inhibition and stenting

36. Inhibition of sPLA2and Endothelial Function: A Substudy of the SPIDER-PCI Trial

39. THE SPLA2 INHIBITION TO DECREASE ENZYME RELEASE AFTER PERCUTANEOUS CORONARY INTERVENTION (SPIDER-PCI) TRIAL

40. FUEL SWITCHING EMPHASIZES IMPORTANCE OF BALANCING OF PLANT COAL PROCESSING EQUIPMENT.

42. The sPLA2 Inhibition to Decrease Enzyme Release after Percutaneous Coronary Intervention (SPIDER-PCI) trial.

43. Change in cycle length during narrow complex tachycardia: what is the mechanism?

Catalog

Books, media, physical & digital resources